# JPMorgan Healthcare Leaders ETF (JDOC): ETF Facts & Distributions

> Markdown mirror of https://www.dividenddata.com/funds/jdoc for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Issuer: J.P. Morgan · Asset class: International Equity
- Strategy: Thematic · Inception: 2023-11-01

The fund primarily allocates its capital to the common stock of companies within the broad healthcare sector, specifically targeting businesses engaged in pharmaceuticals, biotechnology, healthcare services, health technology, medical technology, and life sciences. The adviser seeks out industry leaders in these areas whose potential for future growth, both in scale and longevity, is believed to be underestimated by the market. Under typical market conditions, a minimum of 80% of the fund's assets will be invested in the equity securities of such healthcare-related enterprises.

## Key Facts

| Metric | Value |
|---|---|
| Price | $64.14 |
| Expense Ratio | 0.65% |
| Assets Under Management | $9.6M |
| NAV | $64.00 |
| Holdings Count | 54 |
| Distribution Yield (TTM) | 0.80% |
| Annual Distribution (TTM) | $0.51 /share |
| Distribution Frequency | Annual |
| 52-Week Range | $53.87 – $64.69 |
| Beta | 0.47 |

## Latest Distribution

- Amount: $0.5121 /share
- Ex-date: 2025-12-16
- Pay date: 2025-12-18

## Frequently Asked Questions

### What does JDOC invest in?

The fund primarily allocates its capital to the common stock of companies within the broad healthcare sector, specifically targeting businesses engaged in pharmaceuticals, biotechnology, healthcare services, health technology, medical technology, and life sciences. The adviser seeks out industry leaders in these areas whose potential for future growth, both in scale and longevity, is believed to be underestimated by the market. Under typical market conditions, a minimum of 80% of the fund's assets will be invested in the equity securities of such healthcare-related enterprises.

### What is the expense ratio of JDOC?

JPMorgan Healthcare Leaders ETF (JDOC) charges an expense ratio of 0.65%. This is the annual fee deducted from fund assets to cover management and operations.

### How big is JDOC?

JPMorgan Healthcare Leaders ETF (JDOC) manages $9.6M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure. Funds below ~$50M are at higher risk of liquidation.

### Is JDOC actively managed or an index fund?

JDOC's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

### When was JDOC launched?

JPMorgan Healthcare Leaders ETF (JDOC) launched in November 2023 and is managed by J.P. Morgan.

### How has JDOC performed?

JDOC's total return (price change plus reinvested distributions) is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.

### Does JDOC pay a dividend?

JPMorgan Healthcare Leaders ETF (JDOC) currently distributes little or no income. Trailing-twelve-month yield is 0.80%. Investors looking for income should consider income-focused alternatives. See the Peers tab.

### How often does JDOC pay dividends?

JPMorgan Healthcare Leaders ETF pays dividends Annual. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is JDOC's dividend yield?

JDOC's trailing-twelve-month yield is 0.80%, calculated from the sum of dividends over the past year divided by the current price.

### When is JDOC's next ex-dividend date?

The most recently announced ex-dividend date for JDOC was 2025-12-16. The next ex-date typically follows Annual; once announced it appears at the top of the dividend history table on this page.

### How much will JDOC's expense ratio cost me over 30 years?

On a $10,000 investment compounding at 7% gross return, a 0.65% expense ratio quietly compounds against your balance every year. The Fee Compounding Forecast card above projects the dollar drag for any holding period and assumption you pick. The typical result for a 1.0% expense ratio on a 30-year hold is roughly 25% of the final balance lost to fees.

### How does JDOC charge its expense ratio?

The expense ratio is deducted in tiny daily slices from JDOC's net asset value (NAV). You never see a bill. The price quoted on every exchange is already net of fees. There's no "fee day" to avoid; the cost is continuous and built into the trading price.

### Why does JDOC cost more than a fund like VOO?

JDOC's strategy (current expense ratio 0.65%) is different from a broad-market index tracker like VOO, so its fee belongs to a different cohort. The Cost Verdict card above shows you where JDOC sits within its own category, which is the comparison that actually matters.

### Are there cheaper alternatives to JDOC?

The Lower-Fee Alternatives card above lists ETFs following the same investment strategy as JDOC (0.65%) but at a lower expense ratio. Each row shows the fee gap, the peer's AUM as a liquidity sanity-check, and a direct link to that fund's analysis page. Cheaper price doesn't automatically mean better. Verify the peer holds what you actually want.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/funds/jdoc
- Distribution history: https://www.dividenddata.com/funds/jdoc/dividend
- Holdings & diversification: https://www.dividenddata.com/funds/jdoc/diversification
- Fees & cheaper alternatives: https://www.dividenddata.com/funds/jdoc/expenses
- Peer comparison: https://www.dividenddata.com/funds/jdoc/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.